Retinoic acid syndrome in patients following the treatment of acute promyelocytic leukemia with all-trans retinoic acid

Chang Gung Medical Journal

Volumn 32, Issue 5, 2009, Pages 535-542

  Su, Yung Cheng ^b   Dunn, Po ^a   Shih, Lee Yung ^b   Kuo, Ming Chung ^b   Hung, Chang ^b   Wu, Jin Hou ^b   Lin, Tung Liang ^b   Wang, Po Nan ^b   Tang, Tzung Chih ^b   Hung, Yu Shin ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; High dose steroid; Retinoic acid syndrome

Indexed keywords

CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL STRUCTURE; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DERMATITIS; DRUG FEVER; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; LEG EDEMA; LEUKOCYTE COUNT; LUNG HEMORRHAGE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PLEURA EFFUSION; PROMYELOCYTIC LEUKEMIA; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RETINOIC ACID SYNDROME; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RETROSPECTIVE STUDIES; SYNDROME; TRETINOIN;

EID: 70449450445     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama A, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol 1998;16:78-85. (Pubitemid 28041582)
2. Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low dose chemotherapy, PML-RARα isoform, and CD13 expression in patients with alltrans retinoic acid. Blood 1994;84:3843-3849 (Pubitemid 24979772)
3. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-572
4. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991;78:1413-1419
5. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT. Chomienne C, Degos L. All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 1992;80:2176-2181
6. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Hartmut L, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Banser A, Jacky E, Dombret H, Chastang C, Degos L. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: Results of a multicenter randomized trial. Blood 1993;82:3241-3249 (Pubitemid 23356690)
7. Wu X, Wang X, Qien X, Liu H, Ying J, Yang Z, Yao H. Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia. Am J Hematol 1993;43:183-189 (Pubitemid 23164781)
8. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr. All-trans retinoic acid for acute promyelocytic leukemia. Ann Intern Med 1994;120:278-286
9. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F. AIDA (All-trans retinoic acid plus idarubicin) in newly diagnosed acute promyelocytifc leukemia: a GIMEMA pilot study. Blood 1996;88:1390-1398
10. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, William C, Bloomfield CD, Rowe JM, Wiernik PH. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-1028 (Pubitemid 27430519)
11. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A. Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;96:1014-1021
12. Chou WC, Tang JL, Yao M, Liang YL, Lee FY, Lin MT, Wang CH, Shen MC, Chen YC, Tien HF. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cells counts during all-trans retinoic acid treatment. Leukemia 1997;11:921-928
13. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto J-J, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed APL. Blood 1999;94:1192-1200
14. Sanz MA, Martín G, Rayón C, J Esteve, González M, Díaz-Mediavilla J, Bolufer P, Barragán E, Terol MJ, González JD, Colomer D, Chillón C, Rivas C, Gómez T, Ribera JM, Bornstein R, Román J, Calasanz MJ, Arias J, Álvarez C, Ramos F, Debén G. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-Positive acute promyelocytic leukemia. Blood 1999;94:3015-3021 (Pubitemid 29512705)
15. Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA group. J Clin Oncol 2005;23:7632-7640 (Pubitemid 46291827)
16. Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008;111:2505-2515
17. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992;117:292-296
18. De Botton S, Dombret H, Sanz M, San Miguel J, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Cony Makhoul D, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 1998;92:2712-2718 (Pubitemid 28469083)
19. Tallman MS. Retinoic acid syndrome: a problem of the past. Leukemia 2002;16:160-161
20. Mitelman F. An International System for Human Cytogenetic Nomenclature. Basel: Karger AG, 1995.
21. Nicolls MR, Terada LS, Tuder RM, Prindiville SA, Schwarz MI. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998;158:1302-1305 (Pubitemid 28489037)
22. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704-1709
23. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon M, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med 1991;324:1385-1393
24. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000;95:90-95 (Pubitemid 30017230)
25. Tsai WH, Hsu HC, Lin CC, Ho CK, Kou YR. Role of interleukin-8 and growth-regulated oncogene-α in the chemotactic migration of all-trans retinoic acid-related promyelocytic leukemic cells toward alveolar epithelial cells. Crit Care Med 2007;35:879-885
26. Ko BS, Tang JL, Chen YC, Yao M, Wang CH, Shen MC, Tien HF. Extramedullary relapse after all-trans retonic acid treatment in acute promyelocytic leukemia-the occurrence of retinoic acid syndrome is a risk factor. Leukemia 1999;13:1406-1408 (Pubitemid 29429768)